One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1158/1541-7786.mcr-21-0545
Copy DOI Journal: Molecular cancer research : MCR |  Publication Date: Mar 29, 2022 |
 Citations: 8 |  License type: cc-by |
Affiliation: Hospital Universitario Fundación Jiménez Díaz, Vall d'Hebron Institute of Oncology, Hospital del Mar Research Institute, University of Valencia, Centro de Investigación del Cáncer, Instituto de Investigación Biomédica de Salamanca, Centro de Investigación Biomédica en Red de Cáncer, Hospital Del Mar, European Institute of Oncology, Spanish National Cancer Research CentreInhibition of mTOR increases the antitumor activity of T-DM1, supporting that the combination of mTOR inhibitors and antibody-drug conjugates warrants clinical evaluation in patients with HER2-positive breast cancer.
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
